Article (Scientific journals)
Le médicament du mois. Combinaison fixe atorvastatine-périndopril (Lipercosyl®) pour le traitement de substitution du risque cardiovasculaire.
Lancellotti, Patrizio; ANCION, Arnaud; Scheen, André
2021In Revue Médicale de Liège, 76 (2), p. 128-133
Peer reviewed
 

Files


Full Text
202102_12.pdf
Publisher postprint (1.35 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Amlodipine; Antihypertensive Agents/pharmacology; Atorvastatin; Blood Pressure; Cardiovascular Diseases/drug therapy/prevention & control; Drug Combinations; Heart Disease Risk Factors; Humans; Hypertension/drug therapy; Perindopril/pharmacology; Risk Factors; Atherosclerosis; Cholesterol; Fixed combination; Perindopril; High blood pressure
Abstract :
[en] Fixed combination atorvastatin-perindopril (Lipercosyl®) for substitution treatment of cardiovascular risk management Lipercosyl® is a fixed combination of atorvastatin and perindopril, a cholesterol-lowering and an antihypertensive agent, which allows blood pressure and cholesterol levels to be controlled in hypertensive patients with dyslipidemia : atorvastatin, an inhibitor of HMG-CoA reductase, and perindopril, an angiotensin converting enzyme inhibitor. Six presentations with different dosages of each molecule are available so the treatment can be individualized. Specific precautions of use to each medication must obviously be observed. The use of such a combination helps to ensure a good level of cholesterol while controlling blood pressure.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Lancellotti, Patrizio  ;  Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
ANCION, Arnaud  ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Insuffisance cardiaque - Transplantation
Scheen, André  ;  Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
Language :
French
Title :
Le médicament du mois. Combinaison fixe atorvastatine-périndopril (Lipercosyl®) pour le traitement de substitution du risque cardiovasculaire.
Alternative titles :
[en] Fixed combination atorvastatin-perindopril (Lipercosyl®) for substitution treatment of cardiovascular risk management
Publication date :
2021
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Volume :
76
Issue :
2
Pages :
128-133
Peer reviewed :
Peer reviewed
Available on ORBi :
since 02 September 2021

Statistics


Number of views
123 (2 by ULiège)
Number of downloads
93 (1 by ULiège)

Scopus citations®
 
1
Scopus citations®
without self-citations
1

Bibliography


Similar publications



Contact ORBi